248 related articles for article (PubMed ID: 10920669)
1. [Progressive renal failure. Why blood pressure must now be monitored].
Tepel M; van der Giet M; Zidek W
MMW Fortschr Med; 2000 Jun; 142(25):42-4. PubMed ID: 10920669
[TBL] [Abstract][Full Text] [Related]
2. Treatment of hypertension in chronic kidney disease.
Toto RD
Semin Nephrol; 2005 Nov; 25(6):435-9. PubMed ID: 16298269
[TBL] [Abstract][Full Text] [Related]
3. [Hypertension and renal disease].
Kamper AL; Pedersen EB; Strandgaard S
Ugeskr Laeger; 2009 Jun; 171(25):2109-13. PubMed ID: 19671393
[TBL] [Abstract][Full Text] [Related]
4. Decline of renal function is associated with proteinuria and systolic blood pressure in the morning in diabetic nephropathy.
Suzuki H; Kanno Y; Nakamoto H; Okada H; Sugahara S
Clin Exp Hypertens; 2005; 27(2-3):129-38. PubMed ID: 15835375
[TBL] [Abstract][Full Text] [Related]
5. [How to slow the progression of chronic renal insufficiency].
Rossert J; Ronco P
Rev Prat; 2001 Feb; 51(4):378-84. PubMed ID: 11355601
[TBL] [Abstract][Full Text] [Related]
6. Blood pressure, diabetes and diabetic nephropathy.
Chantrel F; Moulin B; Hannedouche T
Diabetes Metab; 2000 Jul; 26 Suppl 4():37-44. PubMed ID: 10922972
[TBL] [Abstract][Full Text] [Related]
7. [Renoprotective effects of antihypertensives].
Monhart V
Vnitr Lek; 2004 Jul; 50(7):531-6. PubMed ID: 15323261
[TBL] [Abstract][Full Text] [Related]
8. How much must blood pressure be reduced in order to obtain the remission of chronic renal disease?
Pisoni R; Remuzzi G
J Nephrol; 2000; 13(3):228-31. PubMed ID: 10928301
[TBL] [Abstract][Full Text] [Related]
9. Hypertension and progression of renal disease.
Maschio G; Oldrizzi L; Marcantoni C; Rugiu C
J Nephrol; 2000; 13(3):225-7. PubMed ID: 10928300
[TBL] [Abstract][Full Text] [Related]
10. [Are all antihypertensive drugs renoprotective?].
Wolf S; Risler T
Herz; 2004 May; 29(3):248-54. PubMed ID: 15167950
[TBL] [Abstract][Full Text] [Related]
11. Prescribing angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in chronic kidney disease.
Ferrari P
Nephrology (Carlton); 2007 Feb; 12(1):81-9. PubMed ID: 17295666
[TBL] [Abstract][Full Text] [Related]
12. [The influence of antihypertensive treatment on progression of chronic nepropathy].
Petersen LJ; Ladefoged SD; Jensen HA
Ugeskr Laeger; 1997 Jul; 159(31):4745-51. PubMed ID: 9265325
[TBL] [Abstract][Full Text] [Related]
13. Blood pressure, proteinuria and nephropathy in Fabry disease.
Jain G; Warnock DG
Nephron Clin Pract; 2011; 118(1):c43-8. PubMed ID: 21071972
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic controversies in hypertension management: angiotensin converting enzyme (ACE) inhibitors or angiotensin receptor blockers for diabetic nephropathy? A case for ACE inhibitors.
Crook ED; Preddie DC
Ethn Dis; 2002; 12(4):S3-49-52. PubMed ID: 12477155
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin converting enzyme inhibitors and progression of chronic renal failure.
Tolins JP; Raij L
Kidney Int Suppl; 1990 Nov; 30():S118-22. PubMed ID: 2259070
[TBL] [Abstract][Full Text] [Related]
16. [Use of angiotensin converting enzyme inhibitors in nephrology].
Stefanović V; Ivić M; Bogićević M
Srp Arh Celok Lek; 1994; 122(7-8):228-30. PubMed ID: 17974394
[TBL] [Abstract][Full Text] [Related]
17. [Vascular impact of anti-hypertensive treatment and renal protection].
Mogensen CE
Curr Med Res Opin; 2005; 21 Suppl 5():S23-8. PubMed ID: 16197649
[TBL] [Abstract][Full Text] [Related]
18. [Progression of chronic renal insufficiency and its prevention using angiotensin converting enzyme inhibitors and angiotensin antagonists].
Tesar V
Vnitr Lek; 2003 May; 49(5):365-9. PubMed ID: 12908169
[TBL] [Abstract][Full Text] [Related]
19. [Modes of clinical presentation of glomerular diseases].
Dervaux T; Moulin B
Rev Prat; 2003 Nov; 53(18):2013-21. PubMed ID: 15008215
[TBL] [Abstract][Full Text] [Related]
20. [Progression of chronic renal insufficiency].
Rossert J; Fischer E; Venetz JP
Nephrologie; 1999; 20(1):3-7. PubMed ID: 10081030
[No Abstract] [Full Text] [Related]
[Next] [New Search]
